Nurix Therapeutics Shares Are Trading Higher After HC Wainwright & Co. Maintained a Buy Rating and Raised Its Price Target From $19 to $26.
Nurix Therapeutics Shares Are Trading Higher After HC Wainwright & Co. Maintained a Buy Rating and Raised Its Price Target From $19 to $26.
Nurix Therapeutics股票價格上漲，HC Wainwright & Co.維持買入評級，並將目標價從19美元升至26美元。
Nurix Therapeutics Shares Are Trading Higher After HC Wainwright & Co. Maintained a Buy Rating and Raised Its Price Target From $19 to $26.
Nurix Therapeutics股票價格上漲，HC Wainwright & Co.維持買入評級，並將目標價從19美元升至26美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。